Unfortunately, Drugs for Neglected Diseases Initiative North America Inc. has limited available public data.

Create an account for free to request more data.

Drugs for Neglected Diseases Initiative North America Inc. Logo

MIP Score

54

Health Care
Healthcare Policy Research

Drugs for Neglected Diseases Initiative North America Inc.

Mission

The drugs for neglected diseases initiative (dndi), north america supports dndi's global vision and mission to develop new drugs, or new formulations of existing drugs for patients suffering from the most neglected diseases. acting in the public interest, dndi bridges existing r&d gaps in essential drugs for these diseases by initiating and coordinating drug r&d projects in collaboration with the international research community, the public sector, the pharmaceutical industry, and other partners.

Basic Information

Tax-Exempt

Address

40 Rector St, New York, New York, 10006

View all New York charities

Founded in

2007

EIN

20-8774179

Total Assets

$1.155 million

UN Sustainable Development Goals Supported

This organization contributes to the following United Nations Sustainable Development Goals. See the SDG page for more information.

Showing 1 of 1 goals

MIP Score (Beta)

The MIP Score is in beta! We'd love any feedback you may have.

The MIP Score and it's methodology is purely used as a way to visualize how a nonprofits public financial data compares against others. It doesn't reflect the unique circumstances and impact that a nonprofit has.The MIP Score should never be used to say one charity is better than another.

Overall Score

54

30

/100

Program Expense Ratio

73.06%

8

/20

Program Revenue Growth

0.00%

2

/20

Leverage Ratio

0.1987

14

/20

Working Capital Ratio

0.2403

4

/20

Fundraising Efficiency

0

2

/20

Latest Filing Data: Form 990

Fiscal Year:2022

Source:Source: Self-reported by organization

Financial Details

Revenue

CategoryAmountPercentage
Contributions, Gifts, and Grants3.909M99.41%
Program Services00.00%
Investment Income13.39K0.34%
Sales of Non-Inventory Assets00.00%
Other Notable Sources9.995K0.25%
Total Revenue3.932M100.00%